EP is a community where members connect through shared life experiences-- like MS--and so much more. You are not defined by any one thing, so be your true self and find others just like you at
Experience Project.
Posted: Sun Mar 23, 2008 4:58 am Post subject: Opexa News
I suppose this is to be expected for a company without a retail product undergoing an expensive R & D process with its lead candidate.
Opexa Therapeutics 4Q Loss Widens
Opexa Therapeutics' 4th-Quarter Loss Widens on Higher Research and Development Costs
March 18, 2008: 09:22 AM EST
NEW YORK (Associated Press) - Biotechnology company Opexa Therapeutics Inc. said Tuesday its 2007 loss widened on higher research and development expenses.
The company lost $14.7 million, or $2.19 per share, compared with a loss of $12.6 million or $2.35 per share. The company had no revenue in 2007 or 2006. Opexa had about 1.3 million additional shares in 2007.
Opexa did not report fourth-quarter results.
Research and development expenses rose 70 percent to about $13.1 million, primarily due to midstage studies of the company's experimental multiple sclerosis treatment Tovaxin.
Joined: Nov 29, 2006 Posts: 67 Location: Versailles, Kentucky
Posted: Mon Mar 24, 2008 9:56 am Post subject:
Lars wrote:
It's about time for the Cavalry to come riding over the horizon.
Lars
Tim,
Do you have any comments on the business side of Opexa that will help to calm our fears about whether or not Opexa is going to have enough money to complete the IIb, extension and phase III trials?
Sorry about the link, probably won't work. Try going to http://www.pharmafrontierscorp.com/ and then look at the upper left corner under news. I think Opexa is going to make a pitch to Cambria Capital Investors.
Joined: May 04, 2006 Posts: 3155 Location: Mid-Michigan
Posted: Wed Mar 26, 2008 5:21 pm Post subject:
I wish I knew more about stocks and finances.
I might be relying only on faith, but in this regard of the clinical trial, I'm not going to worry until someone from Opexa or someone from the Michigan trial staff tells us to worry about Opexa's financial condition.
Bob
Opexa Therapeutics’ Form 10-K Report Audit Includes ''Going Concern'' Qualification
THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA) noted today that its financial statements for the fiscal year ended December 31, 2007, included in the Company's Report on Form 10-K filed on March 18, 2008, contains a going concern modification from its independent accounting firm, Malone & Bailey, PC.
This announcement is being made in compliance with Nasdaq Marketplace Rule 4350(b)(1)(B), which requires separate disclosure of receipt of an audit opinion that contains a going concern qualification.
In addition, at December 31, 2007, the company failed to meet the continued listing requirement per Nasdaq Marketplace Rule 4310(c)(3)(a) to maintain stockholders’ equity of $2.5 million. With the completion of the February 13, 2008 public equity financing which provided net proceeds of $6.8 million, the company as of the date of this release is in compliance with the Nasdaq continuing listing requirements.
_________________ Wife diagnosed with MS in Feb. 2006 and is a participant in the Tovaxin IIb clinical trial.
Posted: Wed Mar 26, 2008 9:14 pm Post subject: Re: Opexa News
Hi Lyon,
Tim provided some info on the "going concern" statement last November in this thread. Opexa's recent round of fund raising should carry them through the end of this year. Hopefully, the results of the current phase IIB study will get more investors on line so that they can successfully complete a phase III.
NHE
Last edited by NHE on Wed Mar 26, 2008 11:56 pm; edited 1 time in total
Joined: May 04, 2006 Posts: 3155 Location: Mid-Michigan
Posted: Wed Mar 26, 2008 9:32 pm Post subject:
Thanks for looking that up NHE. I knew we had talked about it but I couldn't find the posting.
It doesn't matter to me if at the end of the trial process some huge pharma owns Opexa but I find it unfathomable and unconscionable that something as hopeful as Tovaxin could die during the trial process due to lack of investor interest?
Sure, at this point Tovaxin can only can be made for 50% of those with MS, but 50% of an unimaginable fortune is still a darned near unimaginable fortune.
Bob _________________ Wife diagnosed with MS in Feb. 2006 and is a participant in the Tovaxin IIb clinical trial.
Joined: Mar 22, 2007 Posts: 226 Location: Durango, Co
Posted: Fri Mar 28, 2008 2:44 pm Post subject:
Seems to me that nothing matters except the long anticipated IIB study data. When that information is released the well will either dry up or there will be a financial flood of epic proportions. OK, maybe somewhere in between. Obviously $'s will be directly related to effectiveness.
Hoping for good results,
Lars
Joined: May 04, 2006 Posts: 3155 Location: Mid-Michigan
Posted: Fri Mar 28, 2008 2:54 pm Post subject:
Lars wrote:
Seems to me that nothing matters except the long anticipated IIB study data. When that information is released the well will either dry up or there will be a financial flood of epic proportions. OK, maybe somewhere in between. Obviously $'s will be directly related to effectiveness.
Hoping for good results,
Lars
That's true! I'm with you in that I'm not interested in the "drying up" or "somewhere in between".
The results better be stellar or else Johns Hopkins better prepare the disconbobulating transmogrifyer for a rush in business!
Bob _________________ Wife diagnosed with MS in Feb. 2006 and is a participant in the Tovaxin IIb clinical trial.
Joined: May 04, 2006 Posts: 3155 Location: Mid-Michigan
Posted: Fri Mar 28, 2008 3:28 pm Post subject:
WOW! Something is very, very weird about that.
How well did you get to know the coordinator? Our people, I'm confident I know well enough to judge is they were lying.....in addition to the fact that I don't think someone could pay them to lie.
What's really strange is that there is no reason to think that Tovaxin wouldn't work on progressive MS anyway.
Bob _________________ Wife diagnosed with MS in Feb. 2006 and is a participant in the Tovaxin IIb clinical trial.
Joined: Mar 22, 2007 Posts: 226 Location: Durango, Co
Posted: Fri Mar 28, 2008 3:28 pm Post subject:
Chris,
Holy S**t. I'm sorry for you and your site mates. I have not heard any stories about anyone being dropped. Maybe its time to keep a really close ear to the ground. Big ??????????'s
PS.
Bob, Can you imagine a scenario where all 5 patient would go from RR to Progressive at the same site at the same time. I can't.
Take Care,
Lars
All times are GMT - 6 Hours Goto page 1, 2, 3, 4, 5Next
Page 1 of 5
You cannot post new topics in this forum You cannot reply to topics in this forum You cannot edit your posts in this forum You cannot delete your posts in this forum You cannot vote in polls in this forum
Forum FAQ
Search
Usergroups
Profile
Log in to check your private messages
Log in
That's true! I'm with you in that I'm not interested in the "drying up" or "somewhere in between".